A rapid-response platform to develop & deliver tips against respiratory viral threats, including mers-COV
Other Transaction IDV Awarded Last action
- Contract number
- HR00112090013
- Awardee
-
Autonomous Therapeutics Inc. UEI JFHPX6TUYMU8
- Awarding agency
-
Defense Contract Management Agency
Department of Defense
- Task orders
- 0
Award facts
- Last date to order
- Not on record
- IDV ceiling
- $4,579,822.00
- Contracting staff
- Funding agency
- Defense Advanced Research Projects Agency Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Broad Agency Announcement
- Pricing
- Other
Award details come from SAM.gov/FPDS.
About this IDV
Autonomous Therapeutics Inc. was awarded an Other Transaction IDV by the Defense Advanced Research Projects Agency to develop and deliver therapeutic interfering particles against respiratory viral threats including MERS-CoV. The potential value of this vehicle is $4,579,822 over an unspecified period of performance.
This IDV establishes Autonomous Therapeutics as a rapid-response platform to advance research and delivery of interfering particle treatments for respiratory viruses of concern to the defense sector. The original solicitation sought to procure innovative medical countermeasures against threats such as Middle East respiratory syndrome coronavirus in line with DARPA's focus on emerging infectious diseases posing national security risks. Delivery orders to date have supported development of interfering particles targeting MERS-CoV and other pathogens transmitted via respiratory routes.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$10 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $279,822 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $790,000 | |
| Vendor Address Change | $0 | |
| Funding Only Action | $770,000 | |
| Other Administrative Action | $0 | |
| Original award | $1,500,000 |
Quick answers
Who was awarded contract HR00112090013?
HR00112090013 was awarded to Autonomous Therapeutics Inc. by Defense Contract Management Agency (Department of Defense) on November 8, 2019.
How much is contract HR00112090013 worth?
HR00112090013's own ceiling is $4,579,822.
Which agency awarded contract HR00112090013?
Defense Contract Management Agency (Department of Defense) awarded HR00112090013, with funding from Defense Advanced Research Projects Agency (Department of Defense).
Was contract HR00112090013 competed?
The extent of competition for HR00112090013 was competed.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV